Market revenue in 2023 | USD 23.1 million |
Market revenue in 2030 | USD 42.9 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Surgery |
Fastest growing segment | Intralesional injections |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiotherapy (RT), Intralesional injections, Intravenous Medications, Chemical peeling treatment, Surgery, Topical chemotherapy, Oral Medications |
Key market players worldwide | Bausch Health Companies Inc, Almirall SA, Genentech, Novartis AG ADR, Regeneron Pharmaceuticals Inc, Dr Reddy's Laboratories Ltd ADR, Taro Pharmaceuticals, Accord Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to basal cell carcinoma treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 35.93% in 2023. Horizon Databook has segmented the South Africa basal cell carcinoma treatment market based on radiotherapy (rt), intralesional injections, intravenous medications, chemical peeling treatment, surgery, topical chemotherapy, oral medications covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa's basal cell carcinoma treatment market is witnessing notable growth driven by increasing incidence of skin cancer, rising awareness about early detection, and advancements in diagnostic technologies.
Skin cancer, including NMSC, is a significant public health concern in South Africa due to various factors such as high UV radiation exposure, predominantly fair-skinned population, and outdoor lifestyle.
According to the National Cancer Registry (NCR), in 2019, more than 22,700 people in South Africa were diagnosed with common skin cancer, SCC, and BCC. This suggests an overall increase in skin cancer cases, possibly due to improved screening methods or a genuine increase in incidence.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa basal cell carcinoma treatment market , including forecasts for subscribers. This country databook contains high-level insights into South Africa basal cell carcinoma treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account